Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Halozyme Therapeutics (HALO), Cisco (CSCO), Terreno Realty Corporation (TRNO) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Halozyme Therapeutics (HALO)

31.5% sales growth and 110.23% return on equity

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

Earnings Per Share

As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $1.38.

PE Ratio

Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 21.94. Meaning, the purchaser of the share is investing $21.94 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 110.23%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Halozyme Therapeutics’s EBITDA is 111.78.

Yearly Top and Bottom Value

Halozyme Therapeutics’s stock is valued at $30.28 at 06:22 EST, way under its 52-week high of $59.46 and above its 52-week low of $30.07.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 2.1% and 13.2%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 77.9%, now sitting on 660.12M for the twelve trailing months.

2. Cisco (CSCO)

14.2% sales growth and 27.92% return on equity

Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol based networking and other products related to the communications and information technology industry in the Americas, Europe, the Middle East, Africa, the Asia Pacific, Japan, and China. The company also offers switching portfolio encompasses campus switching as well as data center switching; enterprise routing portfolio interconnects public and private wireline and mobile networks, delivering highly secure, and reliable connectivity to campus, data center and branch networks; wireless products include wireless access points that are standalone, controller appliance-based, switch-converged, and Meraki cloud-managed offerings; and compute portfolio including the cisco unified computing system, hyperflex, and software management capabilities, which combine computing, networking, and storage infrastructure management and virtualization. In addition, it provides Internet for the future product consists of routed optical networking, 5G, silicon, and optics solutions; collaboration products, such as meetings, collaboration devices, calling, contact center, and communication platform as a service; end-to-end security product consists of network security, cloud security, security endpoints, unified threat management, and zero trust; and optimized application experiences products including full stack observability and cloud-native platform. Further, the company offers a range of service and support options for its customers, including technical support and advanced services and advisory services. It serves businesses of various sizes, public institutions, governments, and service providers. The company sells its products and services directly, as well as through systems integrators, service providers, other resellers, and distributors. Cisco Systems, Inc. has strategic alliances with other companies. Cisco Systems, Inc. was incorporated in 1984 and is headquartered in San Jose, California.

Earnings Per Share

As for profitability, Cisco has a trailing twelve months EPS of $2.74.

PE Ratio

Cisco has a trailing twelve months price to earnings ratio of 16.91. Meaning, the purchaser of the share is investing $16.91 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.92%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 11.5% and 25.3%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Cisco’s EBITDA is 47.58.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 3, 2023, the estimated forward annual dividend rate is 1.56 and the estimated forward annual dividend yield is 3.37%.

3. Terreno Realty Corporation (TRNO)

12.3% sales growth and 9.24% return on equity

Terreno Realty Corporation and together with its subsidiaries, the “Company”) acquires, owns and operates industrial real estate in six major coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. All square feet, acres, occupancy and number of properties disclosed in these condensed notes to the consolidated financial statements are unaudited. As of September 30, 2020, the Company owned 219 buildings aggregating approximately 13.1 million square feet, 22 improved land parcels consisting of approximately 85.0 acres and one property under redevelopment expected to contain approximately 0.2 million square feet upon completion. The Company is an internally managed Maryland corporation and elected to be taxed as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2010.

Earnings Per Share

As for profitability, Terreno Realty Corporation has a trailing twelve months EPS of $2.61.

PE Ratio

Terreno Realty Corporation has a trailing twelve months price to earnings ratio of 23.87. Meaning, the purchaser of the share is investing $23.87 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.24%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 25.3%, now sitting on 276.21M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Terreno Realty Corporation’s EBITDA is 20.47.

Sales Growth

Terreno Realty Corporation’s sales growth is 18.6% for the current quarter and 12.3% for the next.

4. Brookline Bancorp (BRKL)

10.8% sales growth and 8.63% return on equity

Brookline Bancorp, Inc. operates as a bank holding company for the Brookline Bank that provide commercial, business, and retail banking services to corporate, municipal, and retail customers in the United States. Its deposit products include demand checking, NOW, money market, and savings accounts. The company's loan portfolio primarily comprises first mortgage loans secured by commercial, multi-family, and residential real estate properties; loans to business entities comprising commercial lines of credit; loans to condominium associations; loans and leases used to finance equipment for small businesses; financing for construction and development projects; and home equity and other consumer loans. It also provides term loans, letters of credit, foreign exchange, cash management, investment advisory, and online and mobile banking services, as well as invests in debt and equity securities. As of December 31, 2021, the company operated 50 full-service banking offices in greater Boston, Massachusetts, and greater Providence, Rhode Island. Brookline Bancorp, Inc. was founded in 1871 and is headquartered in Boston, Massachusetts.

Earnings Per Share

As for profitability, Brookline Bancorp has a trailing twelve months EPS of $1.21.

PE Ratio

Brookline Bancorp has a trailing twelve months price to earnings ratio of 6.73. Meaning, the purchaser of the share is investing $6.73 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.63%.

Yearly Top and Bottom Value

Brookline Bancorp’s stock is valued at $8.14 at 06:22 EST, way below its 52-week high of $15.50 and way above its 52-week low of $7.00.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 10, 2023, the estimated forward annual dividend rate is 0.54 and the estimated forward annual dividend yield is 6.74%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 2.8%, now sitting on 317.4M for the twelve trailing months.

Volume

Today’s last reported volume for Brookline Bancorp is 1178560 which is 65.89% above its average volume of 710439.

5. The Travelers Companies (TRV)

10.4% sales growth and 11.52% return on equity

The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United States and internationally. It operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. The Business Insurance segment offers workers' compensation, commercial automobile and property, general liability, commercial multi-peril, employers' liability, public and product liability, professional indemnity, marine, aviation, onshore and offshore energy, construction, terrorism, personal accident, and kidnap and ransom insurance products. This segment operates through select accounts, which serve small businesses; commercial accounts that serve mid-sized businesses; national accounts, which serve large companies; and national property and other that serve large and mid-sized customers, commercial trucking industry, and agricultural businesses, as well as markets and distributes its products through brokers, wholesale agents, and program managers. The Bond & Specialty Insurance segment provides surety, fidelity, management and professional liability, and other property and casualty coverages and related risk management services through independent agencies and brokers. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners' insurance to individuals through independent agencies and brokers. The Travelers Companies, Inc. was founded in 1853 and is based in New York, New York.

Earnings Per Share

As for profitability, The Travelers Companies has a trailing twelve months EPS of $11.7.

PE Ratio

The Travelers Companies has a trailing twelve months price to earnings ratio of 15.59. Meaning, the purchaser of the share is investing $15.59 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.52%.

Volume

Today’s last reported volume for The Travelers Companies is 313875 which is 78.26% below its average volume of 1443790.

6. Ituran Location and Control Ltd. (ITRN)

10% sales growth and 27.18% return on equity

Ituran Location and Control Ltd., together with its subsidiaries, provides location-based services and wireless communications products. The company's Location-Based Services segment provides stolen vehicle recovery and tracking services, which locate, track, and recover stolen vehicles for its subscribers; fleet management services that enable corporate and individual customers to track and manage their vehicles in real time; and personal locator services that allow customers to protect valuable merchandise and equipment. It also offers on-demand navigation guidance, information, and assistance, including the provision of traffic reports and directions, as well as information on the location of gas stations, car repair shops, post offices, hospitals, and other facilities; and Connected Car, service platform includes a back-office application, a telematics device installed in the vehicle, mobile apps for both IOS and Android users, as well as usage based insurance. This segment serves insurance companies and agents, car manufacturers, dealers and importers, cooperative sales channels, and private subscribers. Its Wireless Communications Products segment provides Base Site, a radio receiver that includes a processor and a data computation unit to collect and send data to and from transponders, and to control centers; Control Center, a center consisting of software used to collect data from various base sites, conduct location calculations, and transmit location data to various customers and law enforcement agencies; navigation and tracking devices installed in vehicles; and SMART, a portable transmitter installed in vehicles that sends a signal to the base site enabling the location of vehicles, equipment, or an individual. As of December 31, 2020, it served approximately 17,680,000 end-users in Israel, Brazil, Argentina, Mexico, Ecuador, Colombia, and the United States. The company was incorporated in 1994 and is headquartered in Azor, Israel.

Earnings Per Share

As for profitability, Ituran Location and Control Ltd. has a trailing twelve months EPS of $1.82.

PE Ratio

Ituran Location and Control Ltd. has a trailing twelve months price to earnings ratio of 11.58. Meaning, the purchaser of the share is investing $11.58 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.18%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Mar 19, 2023, the estimated forward annual dividend rate is 0.56 and the estimated forward annual dividend yield is 2.68%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Ituran Location and Control Ltd.’s EBITDA is 20.39.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 23.3% and 23.3%, respectively.

7. ITT Corporation (ITT)

9.2% sales growth and 16.52% return on equity

ITT Inc. manufactures and sells engineered critical components and customized technology solutions for the energy, transportation, and industrial markets worldwide. The company operates through three segments: Motion Technologies, Industrial Process, and Connect & Control Technologies. The Motion Technologies segment manufactures brake pads, shims, shock absorbers, and energy absorption components; and sealing technologies primarily for the transportation industry, including passenger cars, light- and heavy-duty commercial and military vehicles, buses, and rail. The Industrial Process segment designs and manufactures industrial pumps, valves, and plant optimization systems; and centrifugal process pumps, twin screw, axials, and positive displacement pumps, and water systems, as well as aftermarket solutions, such as repairs and upgrades services. It serves various customers in industries, such as chemical, oil and gas, mining, and other industrial process markets. The Connect & Control Technologies segment designs and manufactures a range of engineered connectors and specialized control components for critical applications supporting various markets, including aerospace and defense, industrial, transportation, medical, and oil and gas. The connector product portfolio includes electrical connectors, such as circular, rectangular, radio frequency, fiber optic, D-sub miniature, micro-miniature, and cable assemblies; and control products consist of fuel and water pumps, valves, electro-mechanical rotary and linear actuators, and pressure, temperature, limit, and flow switches for various aircraft systems. ITT Inc. was founded in 1920 and is headquartered in White Plains, New York.

Earnings Per Share

As for profitability, ITT Corporation has a trailing twelve months EPS of $4.4.

PE Ratio

ITT Corporation has a trailing twelve months price to earnings ratio of 19.38. Meaning, the purchaser of the share is investing $19.38 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.52%.

8. Colgate-Palmolive (CL)

7.2% sales growth and 221.38% return on equity

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Earnings Per Share

As for profitability, Colgate-Palmolive has a trailing twelve months EPS of $1.92.

PE Ratio

Colgate-Palmolive has a trailing twelve months price to earnings ratio of 42.39. Meaning, the purchaser of the share is investing $42.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 221.38%.

Leave a Reply

Your email address will not be published. Required fields are marked *